Recent News

• 09.08.2025 - Morgan Stanley Global Healthcare Conference
• 09.05.2025 - Andrew Fein
• 08.28.2025 - Akero Therapeutics to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
• 08.14.2025 - Akero Therapeutics Announces Lancet Publication of the Phase 2b HARMONY Clinical Trial Demonstrating 96 Weeks Treatment with EFX Reduced Liver Fibrosis in Patients with Pre-cirrhotic MASH
• 08.08.2025 - Akero Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update
• 08.04.2025 - Rami Katkhuda
• 08.04.2025 - Prakhar

Recent Filings

• 08.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.13.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.13.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.12.2025 - 144 Report of proposed sale of securities
• 08.12.2025 - 144 Report of proposed sale of securities
• 08.12.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.12.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.08.2025 - 8-K Current report